Immuneering Corp. (IMRX)
4.61
-0.17
(-3.56%)
USD |
NASDAQ |
Sep 09, 14:39
Immuneering Market Cap : 298.26M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 309.25M |
| September 04, 2026 | 311.84M |
| September 03, 2026 | 326.07M |
| September 02, 2026 | 324.78M |
| September 01, 2026 | 313.78M |
| August 31, 2026 | 322.84M |
| August 28, 2026 | 322.84M |
| August 27, 2026 | 337.07M |
| August 26, 2026 | 333.19M |
| August 25, 2026 | 338.37M |
| August 24, 2026 | 335.13M |
| August 21, 2026 | 342.90M |
| August 20, 2026 | 339.66M |
| August 19, 2026 | 344.84M |
| August 18, 2026 | 325.43M |
| August 17, 2026 | 337.72M |
| August 14, 2026 | 327.37M |
| August 13, 2026 | 336.43M |
| August 12, 2026 | 328.02M |
| August 11, 2026 | 310.55M |
| August 10, 2026 | 293.08M |
| August 07, 2026 | 291.79M |
| August 06, 2026 | 288.55M |
| August 05, 2026 | 284.02M |
| August 04, 2026 | 284.67M |
| Date | Value |
|---|---|
| August 03, 2026 | 269.79M |
| July 31, 2026 | 267.17M |
| July 30, 2026 | 273.63M |
| July 29, 2026 | 262.31M |
| July 28, 2026 | 274.28M |
| July 27, 2026 | 282.04M |
| July 24, 2026 | 279.46M |
| July 23, 2026 | 283.98M |
| July 22, 2026 | 289.16M |
| July 21, 2026 | 288.51M |
| July 20, 2026 | 277.52M |
| July 17, 2026 | 300.16M |
| July 16, 2026 | 309.21M |
| July 15, 2026 | 333.79M |
| July 14, 2026 | 337.03M |
| July 13, 2026 | 333.79M |
| July 10, 2026 | 330.56M |
| July 09, 2026 | 346.73M |
| July 08, 2026 | 357.73M |
| July 07, 2026 | 329.91M |
| July 06, 2026 | 332.50M |
| July 02, 2026 | 335.74M |
| July 01, 2026 | 326.68M |
| June 30, 2026 | 322.80M |
| June 29, 2026 | 326.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 83.08B |
| ACADIA Pharmaceuticals, Inc. | 4.794B |
| Alnylam Pharmaceuticals, Inc. | 34.00B |
| Anika Therapeutics, Inc. | 281.04M |
| Savara, Inc. | 1.110B |
Market Cap Related Metrics
| Price to Book Value | 1.564 |
| Price | 4.61 |
| Earnings Yield | -22.38% |